The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety, pharmacodynamic, and clinical response evaluation of nilotinib and paclitaxel in adults with refractory solid tumors.
 
Sarah Shin
No Relationships to Disclose
 
Geraldine Helen O'Sullivan Coyne
No Relationships to Disclose
 
Shivaani Kummar
Stock and Other Ownership Interests - Arxeon Therapeutics (I); PathomIQ
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Cadila Pharmaceuticals (I); EcoR1 Capital; Gilead Sciences; Harbour BioMed; Mirati Therapeutics; Mundipharma; Oxford BioTherapeutics; Seagen; SpringWorks Therapeutics
Research Funding - ADC Therapeutics (Inst); ADC Therapeutics (Inst); Advenchen Laboratories (Inst); Amgen (Inst); Astex Pharmaceuticals (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Day One Therapeutics (Inst); Dynavax Technologies (Inst); Elevation Oncology (Inst); Genome & Company (Inst); Incyte (Inst); Jounce Therapeutics (Inst); Loxo (Inst); Moderna Therapeutics (Inst); ORIC Pharmaceuticals (Inst); Pfizer (Inst); Plexxikon (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Vincerx Pharma (Inst)
Travel, Accommodations, Expenses - Bayer
 
Murielle Hogu
No Relationships to Disclose
 
Larry V. Rubinstein
No Relationships to Disclose
 
Sarah Miller
No Relationships to Disclose
 
Naoko Takebe
No Relationships to Disclose
 
Lamin Juwara
No Relationships to Disclose
 
Larry Anderson
No Relationships to Disclose
 
Jerry M. Collins
No Relationships to Disclose
 
Richard Piekarz
No Relationships to Disclose
 
Elad Sharon
No Relationships to Disclose
 
Jiuping Jay Ji
No Relationships to Disclose
 
Brandon Miller
No Relationships to Disclose
 
Deborah Wilsker
No Relationships to Disclose
 
Apurva K. Srivastava
No Relationships to Disclose
 
Katherine V. Ferry-Galow
No Relationships to Disclose
 
Ralph E. Parchment
Employment - Leidos Biomedical Research
Stock and Other Ownership Interests - Inovio Pharmaceuticals; Leidos; SciTech Development LLC
Patents, Royalties, Other Intellectual Property - Cambridge University Press for The Biological Basis of Cancer; Named Inventor on US Patent 9,644,037; Named inventor on US Patent US8709379 B2
 
James H. Doroshow
No Relationships to Disclose
 
Alice P. Chen
(OPTIONAL) Uncompensated Relationships - Frontiers in Medicine